More Zelira Therapeutics Ltd. news
Zelira Therapeutics Ltd.ASX: ZLD

ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds Enrolled

Sep 15, 2022 at 2:47 AM UTC · Issued by Zelira Therapeutics Ltd.

Zelira Therapeutics Ltd has released a press release.

View Attachment